Vita Therapeutics Stock

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

Sign up today and learn more about Vita Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Vita Therapeutics Stock

Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Vita utilizes induced pluripotent stem cell technology to engineer specific cell types designed to replace those that are defective in patients.

Funding History

June 2021$32.0M
October 2022$31.0M

Management

Co-Founder and CEO

Douglas Falk

Chief Scientific Officer

Peter Andersen

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo